HRP20030933A2 - Naphtothiazine positive allosteric ampa receptor modulators (paarm) - Google Patents

Naphtothiazine positive allosteric ampa receptor modulators (paarm)

Info

Publication number
HRP20030933A2
HRP20030933A2 HR20030933A HRP20030933A HRP20030933A2 HR P20030933 A2 HRP20030933 A2 HR P20030933A2 HR 20030933 A HR20030933 A HR 20030933A HR P20030933 A HRP20030933 A HR P20030933A HR P20030933 A2 HRP20030933 A2 HR P20030933A2
Authority
HR
Croatia
Prior art keywords
paarm
naphtothiazine
receptor modulators
positive allosteric
ampa receptor
Prior art date
Application number
HR20030933A
Other languages
English (en)
Inventor
Angelo Ceci
Klaus Klinder
Thomas Weiser
Karin Winter
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of HRP20030933A2 publication Critical patent/HRP20030933A2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
HR20030933A 2001-05-17 2003-11-14 Naphtothiazine positive allosteric ampa receptor modulators (paarm) HRP20030933A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10123952A DE10123952A1 (de) 2001-05-17 2001-05-17 Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
PCT/EP2002/005338 WO2002100411A1 (en) 2001-05-17 2002-05-15 Naphtothiazine positive allosteric ampa receptor modulators (paarm)

Publications (1)

Publication Number Publication Date
HRP20030933A2 true HRP20030933A2 (en) 2004-04-30

Family

ID=7685080

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030933A HRP20030933A2 (en) 2001-05-17 2003-11-14 Naphtothiazine positive allosteric ampa receptor modulators (paarm)

Country Status (26)

Country Link
EP (1) EP1404340A1 (xx)
JP (1) JP2004529980A (xx)
KR (1) KR20040007572A (xx)
CN (1) CN1533278A (xx)
AR (1) AR036332A1 (xx)
BG (1) BG108324A (xx)
BR (1) BR0209796A (xx)
CA (1) CA2449189A1 (xx)
CO (1) CO5550460A2 (xx)
CZ (1) CZ20033112A3 (xx)
DE (1) DE10123952A1 (xx)
EA (1) EA006608B1 (xx)
EC (1) ECSP034852A (xx)
EE (1) EE200300566A (xx)
HR (1) HRP20030933A2 (xx)
HU (1) HUP0401273A3 (xx)
IL (1) IL158642A0 (xx)
MX (1) MXPA03010373A (xx)
NO (1) NO20035088L (xx)
NZ (1) NZ530154A (xx)
PL (1) PL364053A1 (xx)
SK (1) SK14222003A3 (xx)
UY (1) UY27290A1 (xx)
WO (1) WO2002100411A1 (xx)
YU (1) YU90403A (xx)
ZA (1) ZA200308466B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009002180A (es) * 2006-08-31 2009-06-05 Univ Alberta Metodo de inhibicion de la depresion respiratoria mediante el uso de moduladores alostericos positivos del receptor ampa.
CN111518058B (zh) * 2020-05-29 2021-03-09 四川大学华西医院 一种噁噻嗪类化合物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4345297A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
AU4711899A (en) * 1998-06-25 2000-01-10 Merck & Co., Inc. Naphtho(1,8-de)thiasin-2-yl methyl carbapenem antibacterials
DE10004572A1 (de) * 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
WO2002100411A1 (en) 2002-12-19
KR20040007572A (ko) 2004-01-24
ECSP034852A (es) 2003-12-24
SK14222003A3 (sk) 2004-05-04
DE10123952A1 (de) 2002-11-21
EP1404340A1 (en) 2004-04-07
IL158642A0 (en) 2004-05-12
NO20035088D0 (no) 2003-11-14
NO20035088L (no) 2003-11-14
PL364053A1 (en) 2004-12-13
HUP0401273A3 (en) 2006-11-28
YU90403A (sh) 2006-05-25
BR0209796A (pt) 2004-06-01
MXPA03010373A (es) 2004-03-16
JP2004529980A (ja) 2004-09-30
CA2449189A1 (en) 2002-12-19
EA006608B1 (ru) 2006-02-24
EE200300566A (et) 2004-02-16
HUP0401273A2 (hu) 2004-10-28
ZA200308466B (en) 2004-05-24
CZ20033112A3 (en) 2004-03-17
NZ530154A (en) 2005-09-30
AR036332A1 (es) 2004-09-01
UY27290A1 (es) 2002-12-31
CN1533278A (zh) 2004-09-29
CO5550460A2 (es) 2005-08-31
EA200301167A1 (ru) 2004-06-24
BG108324A (bg) 2004-12-30

Similar Documents

Publication Publication Date Title
IL158038A0 (en) Allosteric adenosine receptor modulators
IL150912A0 (en) Adenosine receptor modulators
GB2384570B (en) Modulators
AU2003245773A1 (en) Vanilloid receptor modulators
AU2003265128A8 (en) Positive allosteric modulators of the nicotinic acetylcholine receptor
IL159594A0 (en) Adenosine a3 receptor modulators
PL375559A1 (en) Calcium receptor modulating agents
HK1066544A1 (en) ImidazoÄ1,5-AÜpyrimido Ä5,4-DÜ benzazepine derivatives as gaba a receptor modulators
AU2002360487A1 (en) Acyclovir-peptide analogs
AU2003237492A1 (en) Urotensin ii receptor modulators
GB0123379D0 (en) Modulators
AU2002365655A1 (en) 5-ht7 receptor antagonists
AU2002357219A8 (en) Frequency-down-converter using sigma-delta modulators
EP1581309A4 (en) KINASE MODULATORS
HRP20030933A2 (en) Naphtothiazine positive allosteric ampa receptor modulators (paarm)
GB0102876D0 (en) Triboluminescent devices
AU2002366012A1 (en) Transferring device
PL370980A1 (en) Benzothiophenes as adenosine receptor modulators
GB2388034B (en) Fixing devices for prosthetic devices
AU2002249304A1 (en) Novel human gnrh receptor
GB0106338D0 (en) Electro-optic modulators
GB0110662D0 (en) Receptor
GB0114929D0 (en) Receptor
GB0125183D0 (en) Receptor
GB0111959D0 (en) Receptor

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
OBST Application withdrawn